Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osteo-Form SA Powder is a veterinary nutritional supplement developed by Lloyd Pharma (LLOYD, Inc.) to aid in the prevention and treatment of dietary deficiencies of calcium, phosphorus, and vitamins A and D3 in companion animals, including dogs, cats, birds, and reptiles. It features a calcium-to-phosphorus ratio of 1.8-to-1, which is designed to correct mineral deficiencies without causing nutritional imbalances. The formulation also contains vitamins A, D3, and C (ascorbic acid), which are essential for bone and cartilage metabolism, making it particularly beneficial for young growing animals, pregnant or lactating females, and animals recovering from bone fractures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Osteo-Form SA Powder.